Synfacts 2014; 10(3): 0237
DOI: 10.1055/s-0033-1340698
Synthesis of Natural Products and Potential Drugs
© Georg Thieme Verlag Stuttgart · New York

Synthesis of the Four Stereoisomers of Mefloquine

Contributor(s):
Philip Kocienski
Schützenmeister N, Müller M, Reinscheid UM, Griesinger C, * Leonov A. * Max-Planck-Institut für biophysikalische Chemie, Göttingen, Germany
Trapped in Misbelief for Almost 40 Years: Selective Synthesis of the Four Stereoisomers of Mefloquine.

Chem. Eur. J. 2013;
19: 17584-17588
Further Information

Publication History

Publication Date:
17 February 2014 (online)

 

Significance

The antimalarial agent mefloquine hydrochloride (Lariam®) is a racemic compound that contains (+)- and (–)-erythro-mefloquine. Adverse dose-related neuropsychiatric and gastrointestinal effects have been attributed to (–)-erythro-mefloquine, which is a potent blocker of adeno­sine receptors in the central nervous system. The synthesis depicted delivered the (–)-erythro- and (+)-threo-mefloquine diastereoisomers and the identical sequence beginning with (R)-A gave the (+)-erythro and (–)-threo diastereoisomers.


#

Comment

The key step in the synthesis is a Sonogashira coupling (D + EF) followed by a 6π-electrocyclization cascade (GH) leading to an inseparable diastereoisomeric mixture of quinolines I (dr = 3.6:1). After deprotection, the diastereoisomers were separable by chromatography. For another recent synthesis of all four diastereoisomers of mefloquine, see: J. Ding, D. G. Hall ­Angew. Chem. Int. Ed. 2013, 52, 8069.


#
#